Patel Anish
SEC insider (Form 3/4/5 filer). CIK 0001967163. CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN). 32 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in BOULDER, CO.
Companies Patel Anish has filed insider reports for
- Enliven Therapeutics, Inc. (ELVN): Officer, CHIEF OPERATING OFFICER
Patel Anish
CIK: 0001967163
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Enliven Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Feb 12, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirect20K shares- - Jan 9, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect243 shares at avg. $28.50$7K - Jan 9, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect48.1K shares at avg. $27.98$1.3M - Dec 8, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect5K shares at avg. $20.76$103K - Dec 8, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect1.7K shares at avg. $21.78$37K - Nov 7, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect613 shares at avg. $17.94$11K - Nov 7, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect6.1K shares at avg. $17.35$105K - Oct 7, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect6.7K shares at avg. $20.10$134K - Sep 8, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect6.7K shares at avg. $20.24$135K - Aug 7, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect6.3K shares at avg. $18.20$114K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc. | Award | 20,000 | - | $0 | Direct |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 243 | $28.50 | $6,926 | Indirect |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 48,057 | $27.98 | $1,344,837 | Indirect |
| Dec 8, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 4,958 | $20.76 | $102,939 | Indirect |
| Dec 8, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 1,705 | $21.78 | $37,134 | Indirect |
| Nov 7, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 613 | $17.94 | $10,995 | Indirect |
| Nov 7, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 6,054 | $17.35 | $105,039 | Indirect |
| Oct 7, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 6,667 | $20.10 | $133,993 | Indirect |
| Sep 8, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 6,667 | $20.24 | $134,957 | Indirect |
| Aug 7, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 6,262 | $18.20 | $113,949 | Indirect |
1-10 of 32 transactions